[The beginning of the end for interferon therapy? - novel interferon-free treatment options for hepatitis C].
H W
HW
Zimmermann
F
F
Tacke
D000813:Anilides / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use*; D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D047028:Macrocyclic Compounds / Q000627:therapeutic use*; D008297:Male; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors*
D000813:Anilides; D000998:Antiviral Agents; D002219:Carbamates; D007093:Imidazoles; D047028:Macrocyclic Compounds; D017361:Viral Nonstructural Proteins; D014542:Uridine Monophosphate